Synthesis, structure–activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives
Xin Li(North Sichuan Medical University), Danqing Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang-Biao Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Yanxiang Wang(Shandong University), Wuli Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chong−Wen Bi(Chinese Academy of Medical Sciences & Peking Union Medical College), Rong‐Guang Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Nana Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Kaihuan Ren(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 31
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
|Theranostics|2019|185
Loss of Epigenetic Control of <i>Synuclein-γ</i> Gene as a Molecular Indicator of Metastasis in a Wide Range of Human Cancers
|Cancer Research|2005|179
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine
|Arteriosclerosis Thrombosis and Vascular Biology|2005|171